Deborah Siegal

10.8k total citations · 4 hit papers
138 papers, 4.7k citations indexed

About

Deborah Siegal is a scholar working on Internal Medicine, Cardiology and Cardiovascular Medicine and Epidemiology. According to data from OpenAlex, Deborah Siegal has authored 138 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 81 papers in Internal Medicine, 76 papers in Cardiology and Cardiovascular Medicine and 37 papers in Epidemiology. Recurrent topics in Deborah Siegal's work include Venous Thromboembolism Diagnosis and Management (81 papers), Atrial Fibrillation Management and Outcomes (66 papers) and Acute Ischemic Stroke Management (23 papers). Deborah Siegal is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (81 papers), Atrial Fibrillation Management and Outcomes (66 papers) and Acute Ischemic Stroke Management (23 papers). Deborah Siegal collaborates with scholars based in Canada, United States and Netherlands. Deborah Siegal's co-authors include Mark Crowther, Adam Cuker, David García, Atul Humar, Christopher Hillis, Deepali Kumar, James D. Douketis, Janet M. Leeds, Vandana Mathur and Genmin Lu and has published in prestigious journals such as New England Journal of Medicine, Circulation and SHILAP Revista de lepidopterología.

In The Last Decade

Deborah Siegal

128 papers receiving 4.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity

2015 732 citations Deborah Siegal et al. profile →
Laboratory Measurement of the Anticoagulant Activity of the Non–Vitamin K Oral Anticoagulants

2014 323 citations Adam Cuker, Deborah Siegal et al. profile →
2017 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants

2017 263 citations Adam Cuker, Deborah Siegal et al. profile →
2020 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants

2020 201 citations Adam Cuker, Deborah Siegal et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Deborah Siegal Canada	32	2.8k	2.1k	1.0k	707	634	138	4.7k
Michael Spannagl Germany	36	1.6k 0.6×	1.9k 0.9×	814 0.8×	1.1k 1.5×	1.7k 2.7×	130	5.8k
Gregory Piazza United States	33	1.6k 0.6×	2.5k 1.2×	899 0.9×	1.1k 1.6×	365 0.6×	160	4.0k
Roopen Arya United Kingdom	32	1.1k 0.4×	1.5k 0.7×	357 0.4×	863 1.2×	903 1.4×	155	3.6k
Ismaı̈l Elalamy France	32	1.3k 0.5×	1.8k 0.9×	343 0.3×	884 1.3×	1.2k 1.9×	241	4.9k
Grigoris Gerotziafas France	30	1.2k 0.4×	1.7k 0.8×	328 0.3×	799 1.1×	1.1k 1.8×	163	4.3k
Franco Noventa Italy	38	2.8k 1.0×	3.4k 1.6×	2.1k 2.1×	1.3k 1.8×	1.1k 1.8×	81	6.8k
Jean M. Connors United States	41	2.7k 1.0×	3.5k 1.7×	790 0.8×	1.7k 2.3×	1.6k 2.5×	228	8.9k
Alejandro Lazo‐Langner Canada	29	1.0k 0.4×	1.6k 0.8×	291 0.3×	588 0.8×	696 1.1×	169	3.2k
Henry G. Watson United Kingdom	19	1.1k 0.4×	1.2k 0.6×	400 0.4×	559 0.8×	910 1.4×	37	3.0k
Michiel Coppens Netherlands	29	1.8k 0.6×	2.0k 1.0×	373 0.4×	600 0.8×	1.4k 2.2×	134	4.5k

Countries citing papers authored by Deborah Siegal

Since Specialization

Citations

This map shows the geographic impact of Deborah Siegal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deborah Siegal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deborah Siegal more than expected).

Fields of papers citing papers by Deborah Siegal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deborah Siegal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deborah Siegal. The network helps show where Deborah Siegal may publish in the future.

Co-authorship network of co-authors of Deborah Siegal

This figure shows the co-authorship network connecting the top 25 collaborators of Deborah Siegal. A scholar is included among the top collaborators of Deborah Siegal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deborah Siegal. Deborah Siegal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tikkinen, Kari A.O., Deborah Siegal, P.J. Devereaux, et al.. (2025). The CLUE postsurgery VTE risk instrument for abdominal and pelvic surgery: validation of patient risk factor component. Blood Advances. 9(15). 3837–3844.

Siegal, Deborah, Christian Sticherling, Jeff S. Healey, et al.. (2025). Major Bleeding With Apixaban vs Aspirin. JAMA Cardiology. 10(12). 1305–1305.

Siegal, Deborah, Marie‐Pier Arsenault, Andrew Cheung, et al.. (2025). Venous thromboembolism after hospitalization for COVID-19: venous thrombosis virtual surveillance in COVID study. Journal of Thrombosis and Haemostasis. 23(8). 2550–2557. 1 indexed citations

Mithoowani, Siraj, et al.. (2024). Multidisciplinary Expert Guidance for the Management of Severe Bleeding on Oral Anticoagulation: An Algorithm for Practicing Clinicians. Thrombosis and Haemostasis. 125(8). 717–732.

Levy, Jerrold H., Joseph R. Shaw, Lana A. Castellucci, et al.. (2024). Reversal of direct oral anticoagulants: guidance from the SSC of the ISTH. Journal of Thrombosis and Haemostasis. 22(10). 2889–2899. 17 indexed citations

Cuker, Adam, A. Gatt, Nicolas Gendron, et al.. (2024). Anticoagulation for stroke prevention in atrial fibrillation and treatment of venous thromboembolism and portal vein thrombosis in cirrhosis: guidance from the SSC of the ISTH. Journal of Thrombosis and Haemostasis. 22(9). 2653–2669. 14 indexed citations

Delluc, Aurélien, et al.. (2024). Outpatient Management of Cancer-Associated Pulmonary Embolism: A Systematic Review and Meta-Analysis. European Respiratory Journal. 65(4). 2401596–2401596. 1 indexed citations

King, James A., Jenny Godley, Deborah Siegal, et al.. (2024). Evaluating research collaboration networks among venous thromboembolism researchers before and during the COVID-19 pandemic. PubMed. 1(1). 100004–100004. 1 indexed citations

Shaw, Joseph R., Lana A. Castellucci, Deborah Siegal, & Marc Carrier. (2023). DOAC–associated bleeding, hemostatic strategies, and thrombin generation assays - a review of the literature. Journal of Thrombosis and Haemostasis. 21(3). 433–452. 27 indexed citations

10.

Wang, Tzu‐Fei, Deborah Siegal, James D. Douketis, et al.. (2023). Thrombotic and bleeding outcomes following the perioperative interruption of anticoagulation among patients with nonvalvular atrial fibrillation and active cancer. Journal of Thrombosis and Haemostasis. 21(4). 933–943. 2 indexed citations

11.

Kimpton, Miriam, Sonia Cerquozzi, Pierre Villeneuve, et al.. (2023). Assessing the Feasibility of Thromboprophylaxis with Apixaban in JAK2-Positive Myeloproliferative Neoplasm Patients: The Airport-MPN Trial. Blood. 142(Supplement 1). 1823–1823. 1 indexed citations

12.

Siegal, Deborah, Frederik H. Verbrugge, Anne‐Céline Martin, et al.. (2023). Country and health expenditure are major predictors of withholding anticoagulation in atrial fibrillation patients at high risk of stroke. Open Heart. 10(2). e002506–e002506.

13.

Leentjens, Jenneke, et al.. (2023). A scoping review protocol on diagnostic strategies to detect occult malignancies in individuals with ischemic stroke. PLoS ONE. 18(7). e0289048–e0289048.

14.

Collins, Eric B., et al.. (2023). IMPACT OF ANTICOAGULANTS FOR ARTERIAL THROMBOEMBOLISM PREVENTION AMONG AMBULATORY CANCER PATIENTS BY PRIMARY TUMOUR SITE: SYSTEMATIC REVIEW AND META-ANALYSIS. Canadian Journal of Cardiology. 39(10). S252–S253. 1 indexed citations

15.

Exter, Paul L. den, Scott C. Woller, Helia Robert‐Ebadi, et al.. (2022). Management of bleeding risk in patients who receive anticoagulant therapy for venous thromboembolism: Communication from the ISTH SSC Subcommittee on Predictive and Diagnostic Variables in Thrombotic Disease. Journal of Thrombosis and Haemostasis. 20(8). 1910–1919. 27 indexed citations

16.

Wang, Mei, Michael J. Paterson, Lehana Thabane, et al.. (2022). Association of direct oral anticoagulant-proton pump inhibitor cotherapy with adverse outcomes: protocol for a population-based cohort study. BMJ Open. 12(6). e057991–e057991. 3 indexed citations

17.

Leong, Darryl P., Nazanin Aghel, Christopher Hillis, et al.. (2021). Tyrosine kinase inhibitors in chronic myeloid leukaemia and emergent cardiovascular disease. Heart. 107(8). 667–673. 12 indexed citations

18.

Siegal, Deborah & Sonia S. Anand. (2021). Considerations for use of direct oral anticoagulants in arterial disease. Research and Practice in Thrombosis and Haemostasis. 5(4). e12502–e12502. 1 indexed citations

19.

Montrief, Tim, Mary R. Haas, Al’ai Alvarez, et al.. (2020). Thinking Outside the Inbox: Use of Slack in Clinical Groups as a Collaborative Team Communication Platform. AEM Education and Training. 5(1). 121–129. 19 indexed citations

20.

Gupta, Saurabh, et al.. (2020). Intravenous iron therapy for patients with preoperative iron deficiency or anaemia undergoing cardiac surgery reduces blood transfusions: a systematic review and meta-analysis. Interactive Cardiovascular and Thoracic Surgery. 31(2). 141–151. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact